Management of unresectable non-small cell carcinoma of the lung (NSCLC)

Lung Cancer

Volumn 42, Issue 2 SUPPL., 2003, Pages

  Cox, J D ^a   Le Chevalier, T ^b   Arriagada, R ^c   Choy, H ^d   Curran, W J ^e   Fukuoka, M ^f   Harper, P ^g   Komaki, R ^a   Le Pechoux, C ^b   Lievens, Y ^h   Rami Porta, R ⁱ   Ready, N ^j   Sause, W ^k   Stuschke, M ^l   Thatcher, N ^m  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Instituto de Radiomedicina Santiago   (Chile)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g GUY S HOSPITAL   (United Kingdom)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ KUL ^*  (Spain)

^j BROWN UNIVERSITY   (United States)

^k LDS HOSPITAL   (United States)

^l UNIVERSITY HOSPITAL ESSEN   (Germany)

^m CHRISTIE HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONFERENCE PAPER; LUNG NON SMALL CELL CANCER; METASTASIS; PHYSIOLOGY; PRIORITY JOURNAL; RADIATION DOSE; SYMPTOM; THORAX TUMOR; WEIGHT REDUCTION;

EID: 10744224154     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00298-8     Document Type: Conference Paper

References (0)